Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Tofersen: History, Applications & Products

Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). Tofersen is an antisense oligonucleotide that targets the production of superoxide dismutase 1, an enzyme whose mutant form is commonly associated with ALS. It is administered as an intrathecal injection.

Language: English [EN]

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Tofersen topic overview

The analysis highlights History, Applications and Products as prominent areas in the source structure around Tofersen.

Related topics: 20
Source areas: 4
Connected nodes: 24
Extracted relationships: 47
Concept neighborhoods: 17
Bridge connections: 24

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 10 topics

History · 7 topics

Uses · 2 topics

Clinical trials · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com: Monograph
ATC code: N07XX22 (WHO)
CAS Number: 2088232-70-4
DrugBank: DB14782
Formula: C230H317N72O123P19S15
KEGG: D11811

Suggested research paths

A focused starting point derived from the topic graph, ranked independently of the source article order.

Start with these areas

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Uses

Indicated
Superoxide dismutase 1 SOD1

History

Clinical trials

Clinical trial

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Tofersen connects Entity context

The extracted context around Tofersen shows recurring relationship patterns in the source. For example, Tofersen → ALS, Approximately, Asian, III, Neuroscience Institute, Sheffield, Sheffield Institute, SITraN, SOD-1, The, Tofersen's, Translational Neuroscience, University, White Another extracted example is Tofersen → Biogen, Biogen Netherlands, Committee, European Medicines Agency, European Union, Human Use, In February, Ionis Pharmaceuticals, May, Medicinal Products, Qalsody, SOD1, The. Use these groups to spot repeated connection types before inspecting the individual relationships.

Tofersen

Top relations

related to Clinical trials · 14

Tofersen → ALS, Approximately, Asian, III, Neuroscience Institute, Sheffield, Sheffield Institute, SITraN, SOD-1, The, Tofersen's, Translational Neuroscience, University, White

related to history · 13

Tofersen → Biogen, Biogen Netherlands, Committee, European Medicines Agency, European Union, Human Use, In February, Ionis Pharmaceuticals, May, Medicinal Products, Qalsody, SOD1, The

Legal status · 3

Tofersen → CA: ℞-only, EU: Rx-only, US: ℞-only

related to Uses · 3

Tofersen → ALS, SOD1, SOD1-ALS

AHFS/Drugs.com · 1

Tofersen → Monograph

ATC code · 1

Tofersen → N07XX22 (WHO)

CAS Number · 1

Tofersen → 2088232-70-4

DrugBank · 1

Tofersen → DB14782

Formula · 1

Tofersen → C230H317N72O123P19S15

KEGG · 1

Tofersen → D11811

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

als us treatment drug medication qalsody intrathecal superoxide dismutase approved use clinical name eu administration mutation sod1 amyotrophic lateral sclerosis

Tofersen relationships Subject–Predicate–Object triples

TTTA extracted 47 structured relationships around Tofersen. Examples in this analysis include Tofersen → AHFS/Drugs.com → Monograph and Tofersen → ATC code → N07XX22 (WHO). The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Tofersen	AHFS/Drugs.com	Monograph	1.00	infobox
Tofersen	ATC code	N07XX22 (WHO)	1.00	infobox
Tofersen	CAS Number	2088232-70-4	1.00	infobox
Tofersen	DrugBank	DB14782	1.00	infobox
Tofersen	Formula	C230H317N72O123P19S15	1.00	infobox
Tofersen	KEGG	D11811	1.00	infobox
Tofersen	Legal status	CA: ℞-only	1.00	infobox
Tofersen	Legal status	US: ℞-only	1.00	infobox
Tofersen	Legal status	EU: Rx-only	1.00	infobox
Tofersen	License data	US DailyMed: Tofersen	1.00	infobox
Tofersen	MedlinePlus	a623024	1.00	infobox
Tofersen	Molar mass	7127.85 g·mol−1	1.00	infobox
Tofersen	PubChem CID	172873401	1.00	infobox
Tofersen	Routes of administration	Intrathecal	1.00	infobox
Tofersen	Trade names	Qalsody	1.00	infobox
Tofersen	UNII	2NU6F9601K	1.00	infobox
Tofersen	is a	antisense oligonucleotide that targets the production of superoxide dismutase 1	0.90	text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Tofersen bring nearby vocabulary together. In this analysis, examples include Approved, Als and Associated. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Tofersen
- Approved
- Als
- Associated
- Eu
- Medical
- Dismutase
- Superoxide
- Use
- Treatment
- Us
- Administration
- Amyotrophic
tofersen
- Approved
- Als
- Associated
- Eu
- Medical
- Dismutase
- Superoxide
- Use
- Treatment
- Us
- Administration
- Amyotrophic
superoxide dismutase 1
- Dismutase
- Superoxide
- Associated
- Qalsody
- Sod1
- Administration
- Eu
- European
- Intrathecal
- Lateral
- Medicinal
- Name
food and drug administration
- Fda
- Us
- Associated
- Eu
- Intrathecal
- Medication
- Name
- Patients
- Clinical
- Dismutase
- Mutation
- Qalsody
amyotrophic lateral sclerosis
- Lateral
- Sclerosis
- Qalsody
- Brand
- Sold
- Treatment
- European
- Medication
- Medicinal
- Name
- Product
- Dismutase
committee for medicinal products for human use
- Product
- European
- Medical
- Approved
- Sclerosis
- Amyotrophic
- Eu
- Lateral
- Medicinal
- Qalsody
- Sod1
- Superoxide
medication
- Sold
- Administration
- Amyotrophic
- Fda
- Lateral
- Name
- Sclerosis
- Qalsody
- Drug
- Treatment
- Us
- Als
first-in-class medication
- Sold
- Administration
- Amyotrophic
- Fda
- Lateral
- Name
- Sclerosis
- Qalsody
- Drug
- Treatment
- Us
- Als

Connections between topic areas Semantic bridges

For Tofersen, one of the stronger structural bridges in this analysis connects Tofersen with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Tofersen — Overview · splits 14 ⟂ 11

Tofersen — History · splits 17 ⟂ 8

Tofersen — Uses · splits 22 ⟂ 3

Map overview Semantic statistics

Tofersen

Nodes25

Edges24

Triples47

Avg. degree1.92

Density0.08

Components1

Source & methodology

TTTA analyzes the structure around Tofersen to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Tofersen · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.